Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs Teradyne, Inc. (TER) Price & Performance

AstraZeneca plcTrade
Teradyne, Inc.Trade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Teradyne, Inc. — how do they compare? AstraZeneca plc trades at $158.03 (market cap $248.14B), while Teradyne, Inc. trades at $390.66 (market cap $59.34B). The key difference: AstraZeneca plc is far larger — about 4.2× Teradyne, Inc.'s market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.

AZNTER
Market Cap
$248.14B$59.34B
Sector
HealthTechnology
52-Week High
$209.48$483.84
52-Week Low
$147.06$109.30
Enterprise Value
$275.41B$59.09B
Dividend Yield
2.01%0.14%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Read more on TER